Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Sumitomo Mitsui Banking Corporation have signed a master agreement to establish a joint venture company dedicated to the incubation of early drug discovery programs, primarily originating from Japan and toward the creation of innovative therapeutics.   According to the companies, in recent years, advancing academic discoveries from bench to bedside has presented a major challenge when it comes to unleashing the full potential of ...